Marazzi, G.; Caminiti, G.; Perrone, M.A.; Campolongo, G.; Cacciotti, L.; Giamundo, D.M.; Iellamo, F.; Severino, P.; Volterrani, M.; Rosano, G.
Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study. J. Cardiovasc. Dev. Dis. 2024, 11, 286.
https://doi.org/10.3390/jcdd11090286
AMA Style
Marazzi G, Caminiti G, Perrone MA, Campolongo G, Cacciotti L, Giamundo DM, Iellamo F, Severino P, Volterrani M, Rosano G.
Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study. Journal of Cardiovascular Development and Disease. 2024; 11(9):286.
https://doi.org/10.3390/jcdd11090286
Chicago/Turabian Style
Marazzi, Giuseppe, Giuseppe Caminiti, Marco Alfonso Perrone, Giuseppe Campolongo, Luca Cacciotti, Domenico Mario Giamundo, Ferdinando Iellamo, Paolo Severino, Maurizio Volterrani, and Giuseppe Rosano.
2024. "Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study" Journal of Cardiovascular Development and Disease 11, no. 9: 286.
https://doi.org/10.3390/jcdd11090286
APA Style
Marazzi, G., Caminiti, G., Perrone, M. A., Campolongo, G., Cacciotti, L., Giamundo, D. M., Iellamo, F., Severino, P., Volterrani, M., & Rosano, G.
(2024). Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study. Journal of Cardiovascular Development and Disease, 11(9), 286.
https://doi.org/10.3390/jcdd11090286